scholarly journals Mushrooms (Basidiomycetes) as a significant source of biologically active compounds for malaria control

2021 ◽  
Author(s):  
Gervais Mouthé Happi ◽  
Livine Zemo Meikeu ◽  
Klev Gaïtan Sikam ◽  
Liliane Clotilde Dzouemo ◽  
Jean Duplex Wansi
Keyword(s):  
Malaria Control ◽  
Chemical Constituents ◽  
Large Family ◽  
Biologically Active ◽  
Significant Source ◽  
Ganoderic Acid ◽  
Scientific Publications ◽  
Medicinal Mushrooms ◽  
Language Restriction

Mushrooms represent a large family of fleshy fungi that have been of high interest since ancient ages due to their medicinal and nutritional importance. Therefore, it can represent a significant source of bioactive compounds in malaria control. The few numbers of studies on <i>in vitro</i> antiplasmodial and insecticidal properties of their extracts and chemical constituents led to interesting results reported in numerous scientific publications. This review aims to provide a comprehensive compilation of literature up to 2021 on the antiplasmodial, insecticidal as well as cytotoxic chemical constituents of medicinal mushrooms that can help in the management of malaria both against the parasite <i>Plasmodium falciparum</i> and the mosquitoe <i>Anopheles stephensis</i> acting as a vector of malaria through its bites. For this purpose, some searches have been done in some online libraries using keywords like Basidiomycete, mushroom, malaria, <i>Plasmodium</i>, <i>Anopheles</i> and antiplasmodial without language restriction. Among the reported compounds, 51 selected ones displayed significant antiplasmodial potency with IC<sub>50</sub> values lower than 10 μM against <i>P. falciparum</i> strains sensitive or resistant to chloroquine. For instance, ganoderic acid AW1 demonstrated a strong antiplasmodial activity with IC<sub>50</sub> of 257.8 nM against <i>P. falciparum</i> D6, while strong activities were displayed by ganoweberianones A (IC<sub>50</sub> = 0.050 μM) and B (IC<sub>50</sub> = 0.46 μM) against <i>P. falciparum</i> K1. Moreover, some mushroom methanol extracts demonstrated good larvicidal and ovicidal activities against <i>Anopheles stephensis</i>. This paper provides further insights into the development of new antiplasmodial drugs or new potent eco-friendly pesticides to control mosquito vectors.

Edible Mushrooms: Novel Medicinal Agents to Combat Metabolic Syndrome and Associated Diseases

2020 ◽  
Vol 26 (39) ◽  
pp. 4970-4981
Author(s):  
Yu-Tang Tung ◽  
Chun-Hsu Pan ◽  
Yi-Wen Chien ◽  
Hui-Yu Huang
Keyword(s):  
Metabolic Syndrome ◽  
Unsaturated Fatty Acids ◽  
Edible Mushroom ◽  
Biologically Active ◽  
Edible Mushrooms ◽  
Beta Glucan ◽  
Medicinal Mushrooms ◽  
Associated Diseases ◽  
Increased Risk

Metabolic syndrome is an aggregation of conditions and associated with an increased risk of developing diabetes, obesity and cardiovascular diseases (CVD). Edible mushrooms are widely consumed in many countries and are valuable components of the diet because of their attractive taste, aroma, and nutritional value. Medicinal mushrooms are higher fungi with additional nutraceutical attributes having low-fat content and a transisomer of unsaturated fatty acids along with high fiber content, biologically active compounds such as polysaccharides or polysaccharide β-glucans, alkaloids, steroids, polyphenols and terpenoids. In vitro experiments, animal models, and even human studies have demonstrated not only fresh edible mushroom but also mushroom extract that has great therapeutic applications in human health as they possess many properties such as antiobesity, cardioprotective and anti-diabetic effect. They are considered as the unmatched source of healthy foods and drugs. The focus of this report was to provide a concise and complete review of the novel medicinal properties of fresh or dry mushroom and extracts, fruiting body or mycelium and its extracts, fiber, polysaccharides, beta-glucan, triterpenes, fucoidan, ergothioneine from edible mushrooms that may help to prevent or treat metabolic syndrome and associated diseases.

scholarly journals Effect of bioactive extracts with high cytokinin content from micelial biomass of Hericium coralloides and Fomitopsis officinalis on tumor cells in vitro

2019 ◽  
Vol 79 (3) ◽  
pp. 31-37
Author(s):  
N. Vedenicheva ◽  
G. Al-Maali ◽  
N. Bisko ◽  
I. Kosakivska ◽  
L. Garmanchuk ◽  
...  
Keyword(s):  
Glucose Uptake ◽  
Tumor Cells ◽  
Wide Spectrum ◽  
Zeatin Riboside ◽  
Biologically Active ◽  
Therapeutic Effects ◽  
Mycelial Biomass ◽  
Medicinal Mushrooms ◽  
Methanolic Extracts

Phytohormones cytokinins are known to promote cell division in plants. Contrary, in animal's and human's tissues they induce apoptosis and block the cell cycle of a wide spectrum of tumour cells. Therapeutic effects of cytokinins, specifically their anticancer and immunomodulatory actions are similar to those of medicinal mushrooms. We detected cytokinins in mycelial biomass of two species of medicinal mushrooms growing in vitro (Fomitopsis officinalis strain 5004 and Hericium coralloides strain 2332) using HPLC-MS. Trans-zeatin, zeatin riboside, zeatin-O-glucoside and isopentenyladenine were found. Crude extracts and purified cytokinin fractions from mycelial biomass were tested on the growth and development of cultures of tumor cells lines: Hela (MTT-assay), T24/83 (viability and level apoptotic cells) and HepG2 (consumption of glucose). The effect of cytokinin fraction from mycelial biomass of Fomitopsis officinalis on pathogenic cells was higher compared to Hericium coralloides one. The data obtained revealed a higher cytotoxic/cytostatic effect of the purified cytokinin fractions in comparison with crude methanolic extracts; also higher apoptotic index was found. Under the influence of the test agents the intensification of glucose uptake into cells was observed. This indicator was higher for crude mushroom mycelium extracts, whereas under the action of purified fractions the glucose uptake rate was lower, thus decreased glycolysis level was recorded. Also, the effect of both crude extract and purified fraction from H. coralloides mycelial biomass on glucose uptake in the conditioned medium was lower against F. officinalis.These results confirm the assumption that biologically active substances of medicinal mushrooms with high pharmacological potential include cytokinins.

Traditional Uses, Chemical Constituents and Biological Activities of Plants from the Genus Sanguisorba L.

2017 ◽  
Vol 45 (02) ◽  
pp. 199-224 ◽  
Author(s):  
Zefeng Zhao ◽  
Xirui He ◽  
Qiang Zhang ◽  
Xiaoyang Wei ◽  
Linhong Huang ◽  
...  
Keyword(s):  
Quality Control ◽  
Biological Activities ◽  
Chemical Constituents ◽  
Control Measures ◽  
Biologically Active ◽  
Bioactive Metabolites ◽  
Clinical Value ◽  
Wide Range

Plants from the genus Sanguisorba have been treated as medicinal ingredients for over 2000 years. This paper reviews advances in the botanical, phytochemical and pharmacological studies of the genus. To date, more than 120 chemical constituents have been isolated and identified from these plants, especially from S. officinalis and S. minor. Among these compounds, triterpenoids, phenols and flavonoids are the primary biologically active constituents. Triterpenoids can be used as quality control markers to determine the quality of medicinal materials and their preparations. In vivo and in vitro studies have shown that plants from the genus Sanguisorba exhibit a wide range of pharmacological properties, including hemostatic, antibacterial, antitumor, neuroprotective and hypoglycemic activities. In Chinese medical practice, many drugs (e.g., tablets and powders) that contain S. officinalis roots have been used to treat leukopenia, hemorrhaging and burns. However, there is still a multitude of Sanguisorba species that have garnered little or no attention. Indeed, there are few reports concerning the clinical use and toxic effects of these plants. Further attention should be focused on the study of these species in order to gather information on their respective toxicology data, any relevant quality-control measures, and the clinical value of the crude extracts, active compounds, and bioactive metabolites from Genus Sanguisorba.

Properties of Bifidobacteria and Their Use for Scientific and Practical Purposes

2021 ◽  
Vol 37 (3) ◽  
pp. 3-10
Author(s):  
L.I. Nikolaeva
Keyword(s):  
Bacterial Infections ◽  
Biological Properties ◽  
Biologically Active ◽  
Recombinant Vaccines ◽  
Scientific Publications ◽  
Wide Range ◽  
Normal Human ◽  
Made In

Bifidobacteria occupy a special place among various representatives of normal human microbiota. A wide range of probiotic preparations has been obtained based on cultivated strains of various bifidobacteria of the intestinal microbiota. A number of scientific publications noted the immunomodulatory, anticarcinogenic, and antiviral properties of bifidobacteria in vitro and in vivo. Recently, progress has been made in the research and application of this group of microorganisms in genetic engineering. It was established that vaccines against viral and bacterial infections and antitumor substances can be developed on the basis of various strains of bifidobacteria. Bifidobacteria can also be used as adjuvants for other vaccines, as well as delivery systems for biologically active substances to tumors. The prospects for the use of bifidobacteria for the development of recombinant vaccines are discussed. bifidobacteria, medical and biological properties, recombinant vaccines, drug delivery, adjuvants, plasmids This work was funded by the Epidemiology and Microbiology National Research Center. The authors are grateful to V. V. Kuprianov for valuable comments on the text of the review.

scholarly journals PRELIMINARY SCREENING OF PHYTOCHEMICALS AND ANTIPROLIFERATIVE AND ANTI-INFLAMMATORY PROPERTIES OF THESPESIA POPULNEA (L.) SOLAND LEAF EXTRACTS

2018 ◽  
Vol 11 (5) ◽  
pp. 382
Author(s):  
Megha Kb ◽  
Sanith Cheriyamundath ◽  
Joseph Madassery ◽  
Elyas Kk
Keyword(s):  
Leaf Extract ◽  
Chemical Constituents ◽  
Biologically Active ◽  
Bioactive Molecules ◽  
Phytochemical Analysis ◽  
Leaf Extracts ◽  
Thespesia Populnea ◽  
Wide Range ◽  
Anti Inflammatory

Objective: Plant-derived bioactive molecules are providing infinite opportunities for new drug development as they possess a wide range of actions against diseases with lesser side effects. The present study is made to analyze the qualitative phytochemicals and to evaluate in vitro antiproliferative and anti-inflammatory potentials of leaf extracts of Thespesia populnea. Methods: T. populnea leaf extracts were prepared sequentially according to the increasing polarity of the solvents, i.e., petroleum ether, chloroform, ethyl acetate, and methanol. Qualitative phytochemical analysis was performed to identify the chemical constituents of the extracts, and antiproliferative properties were evaluated against different cell lines using the 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide assay. Bovine serum albumin anti-denaturation assay was done to identify the anti-inflammatory activity.Results: Phytochemical analysis of the extracts revealed the presence of alkaloids, terpenoids, glycosides, tannins, flavonoids, and phenolics. The chloroform extract (CHFE) of T. populnea has a dose-dependent antiproliferative effect against acute T-cell leukemia (Jurkat E6-1), prostate Grade IV adenocarcinoma (PC-3), mouse fibroblast (L-929), and monkey kidney normal (Vero) cells. Their inhibitory concentration 50% (IC50) values were found to be 35.73±0.94 μg/ml for Jurkat E6-1, 60.79±1.84 μg/ml for PC-3, 60.88±1.45 μg/ml for L-929, and 83.482±2.05 μg/ml for Vero, respectively. CHFE also displayed the anti-inflammatory potential.Conclusion: The chloroform leaf extract of T. populnea possesses potent antiproliferative and anti-inflammatory activity. These properties present in leaf extract may be explained by the presence of biologically active constituents.

scholarly journals Isolation and structural elucidation of biologically active phospholipids from Scytonema julianum (cyanobacteria)

2002 ◽  
Vol 367 (1) ◽  
pp. 287-293 ◽  
Author(s):  
Smaragdi ANTONOPOULOU ◽  
Alexandra OIKONOMOU ◽  
Haralabos C. KARANTONIS ◽  
Elizabeth FRAGOPOULOU ◽  
Adriani PANTAZIDOU
Keyword(s):  
Platelet Aggregation ◽  
Neutral Lipids ◽  
Second Messengers ◽  
Platelet Activating Factor ◽  
Large Family ◽  
Biologically Active ◽  
Bioactive Metabolites ◽  
Rabbit Platelet ◽  
Filamentous Cyanobacterium

The role of platelet-activating factor (PAF) as a mediator appeared in rather primitive organisms like protozoans and was maintained in more evolved organisms. No reports exist for the presence of PAF or PAF analogues—or even compounds that exhibit PAF-like activity—in cyanobacteria, even though they belong to a a group of organisms at a low evolutionary level where the content of alkylacyl forms of ether lipids is expected to be high. In addition, cyanobacteria serve as a rich source of novel bioactive metabolites. In the present study the total lipids of a strain of Scytonema julianum, a filamentous cyanobacterium isolated from a Greek cave, were separated into neutral lipids and phospholipids, the latter being further fractionated by HPLC. Each phospholipid fraction was tested in vitro for its ability to inhibit PAF-, arachidonic acid- and ADP-induced washed-rabbit-platelet aggregation and/or to cause platelet aggregation. Two types of phospholipids causing platelet aggregation were detected and shown to be an acetylsphingomyelin and an acylacetylglycerol phosphoacetylated glycolipid. The existence of the sphingomyelin analogues is very important, since ceramides, cerebrosides and related lipids are intracellular second messengers. The identification of the phosphoglycoglycerolipid demonstrates a new type of lipid in cyanobacteria, namely one that exhibits a biological activity very similar to that of PAF. Its presence reinforces the concept that PAF is a member of a large family of lipid mediators, apparently having different physiological roles in prokaryotic and eukaryotic organisms. In addition, Scytonema julianum contains a phosphatidylcholine (C16:0/18:2), even though bacteria in general seldom contain choline-containing phosphoacylglycerols.

scholarly journals Flavonoids: A Myth or a Reality for Cancer Therapy?

Molecules ◽  
2021 ◽  
Vol 26 (12) ◽  
pp. 3583
Author(s):  
Cinzia Forni ◽  
Massimiliano Rossi ◽  
Ilaria Borromeo ◽  
Giordana Feriotto ◽  
Giovambattista Platamone ◽  
...  
Keyword(s):  
Bacterial Infections ◽  
Epidemiological Studies ◽  
Biologically Active ◽  
In Vivo Studies ◽  
Plant Metabolites ◽  
Scientific Publications ◽  
Anticancer Properties ◽  
Risk Of Cancer

Nutraceuticals are biologically active molecules present in foods; they can have beneficial effects on health, but they are not available in large enough quantities to perform this function. Plant metabolites, such as polyphenols, are widely diffused in the plant kingdom, where they play fundamental roles in plant development and interactions with the environment. Among these, flavonoids are of particular interest as they have significant effects on human health. In vitro and/or in vivo studies described flavonoids as essential nutrients for preventing several diseases. They display broad and promising bioactivities to fight cancer, inflammation, bacterial infections, as well as to reduce the severity of neurodegenerative and cardiovascular diseases or diabetes. Therefore, it is not surprising that interest in flavonoids has sharply increased in recent years. More than 23,000 scientific publications on flavonoids have described the potential anticancer activity of these natural molecules in the last decade. Studies, in vitro and in vivo, show that flavonoids exhibit anticancer properties, and many epidemiological studies confirm that dietary intake of flavonoids leads to a reduced risk of cancer. This review provides a glimpse of the mechanisms of action of flavonoids on cancer cells.

scholarly journals MEDICINAL PROPERTIES OF HERICIUM ERINACEUS

2021 ◽  
Vol 6 (10(60)) ◽  
pp. 3-8
Author(s):  
Bulat Musulmanbekovich Aikeshev ◽  
Ayaulym Arystanbay
Keyword(s):  
Cognitive Abilities ◽  
Edible Mushroom ◽  
Biologically Active ◽  
Medicinal Mushrooms ◽  
Hericium Erinaceus ◽  
Parkinson’S Diseases ◽  
History Of ◽  
Medicinal Properties ◽  
History Of Use

Medicinal mushrooms have become an attractive topic due to their bioactive compounds potentially useful for therapeutic use. Among the growing popularity of medicinal mushrooms is Hericium erinaceus. Hericium erinaceus is a medicinal edible mushroom with a long history of use in traditional Chinese medicine as well as in other countries of the East. Along with this, several of its biologically active compounds served as the basis for the creation of nutritional supplements. Its fruiting bodies and mycelium are rich in active substances that promote health. Tests of substances extracted from this fungus in animals and in vitro have given good results. They are beginning to be used in the treatment of cancer, liver diseases, Alzheimer’s and Parkinson’s diseases, and wound healing. They improve cognitive abilities, support the nervous and immune systems.

GC-MS analysis and in vitro antibacterial potential of volatile chemical constituents from leaves of Murrayakoenigii L. Spreng

2017 ◽  
Vol VI (I) ◽  
pp. 143-147
Author(s):  
Itzaz Aslam ◽  
Faiza Aslam ◽  
Shahzad Qamar ◽  
Saiqa Ishtiaq ◽  
Muhammad Shaharyar Khan Afridi ◽  
...  
Keyword(s):  
Chemical Constituents ◽  
Ms Analysis ◽  
Antibacterial Potential

Properties and Biotechnological Application of mutant Derivatives of Mini-intein PRP8 from Penicillium chrysogenum with Improved Control of C-terminal Processing

2019 ◽  
Vol 35 (6) ◽  
pp. 91-101
Author(s):  
F.A. Klebanov ◽  
S.E. Cheperegin ◽  
D.G. Kozlov
Keyword(s):  
Penicillium Chrysogenum ◽  
Protein Denaturation ◽  
Biologically Active ◽  
Cultivation Temperature ◽  
Target Proteins ◽  
E Coli ◽  
Complete Inactivation ◽  
Target Molecules ◽  
Proteins And Peptides

Mutant variants of mini-intein PRP8 from Penicillium chrysogenum (Int4b) with improved control of C-terminal processing were characterized. The presented variants can serve as a basis for self-removed polypeptide tags capable of carrying an affine label and allowing to optimize the process of obtaining target proteins and peptides in E. coli cells. They allow to synthesize target molecules in the composition of soluble and insoluble hybrid proteins (fusions), provide their afnne purification, autocatalytic processing and obtaining mature target products. The presented variants have a number of features in comparison with the known prototypes. In particular the mutant mini-intein Int4bPRO, containing the L93P mutation, has temperature-dependent properties. At cultivation temperature below 30 °C it allows the production of target molecules as part of soluble fusions, but after increasing of cultivation temperature to 37 °C it directs the most of synthesized fusions into insoluble intracellular aggregates. The transition of Int4bPRO into insoluble form is accompanied by complete inactivation of C-terminal processing. Further application of standard protein denaturation-renaturation procedures enable efficiently reactivate Int4bPRO and to carry out processing of its fusions in vitro. Two other variants, Int4b56 and Int4b36, containing a point mutation T62N or combination of mutations D144N and L146T respectively, have a reduced rate of C-terminal processing. Their use in E. coli cells allows to optimize the biosynthesis of biologically active target proteins and peptides in the composition of soluble fusions, suitable for afnne purification and subsequent intein-dependent processing without the use of protein denaturation-renaturation procedures. intein, fusion, processing, processing rate, gelonin The work was supported within the framework of the State Assignment no. 595-00003-19 PR.

Sign in / Sign up

Export Citation Format

Share Document